Recombinant COVID-19 Vaccine(CHO Cell)

Recombinant COVID-19 Vaccine(CHO Cell)

Products
Recombinant COVID-19 Vaccine(CHO Cell)
Recombinant COVID-19 Vaccine(CHO Cell)

Information

Zifivax is the first approved Recombinant COVID vaccine, there are more than 300million doses used worldwide.
Main Categories
Pharmaceutical Products / ATC coding
All Categories
Antiinfectives for Systemic usePharmaceutical Products / ATC codingVaccines
Chongqing Zhifei Biological Products Co.Ltd.Chongqing Zhifei Biological Products Co., Ltd. is the largest listed vaccine company in China?which has its presence in biological product industry in 2002.The Company achieved an operating income of RMB38.3 billion In 2022 with the support of its nearly 7000 employees.As a high-tech biological enterprise integrating the R&D, production, marketing, distribution as well as import & export, Zhifei mainly engages in the production of vaccines for human use. Our research channels cover many indications extensively: like COVID-19, tuberculosis, meningitis, etc.

Log in

See all the content and easy-to-use features by logging in or registering!